NCT05016635

Brief Summary

Subarachnoid hemorrhage (SAH) is the extravasation of blood into the subarachnoid space from traumatic or nontraumatic origin. There is a paucity of data on the burden of SAH in African countries. In this study, we analyzed data from patients in the largest neurovascular center in Senegal to determine the sex- and age-adjusted burden of SAH in Senegal.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
388

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 26, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 16, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 16, 2021

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

August 17, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 23, 2021

Completed
Last Updated

August 23, 2021

Status Verified

August 1, 2021

Enrollment Period

4 months

First QC Date

August 17, 2021

Last Update Submit

August 17, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Disability Adjusted Life Years

    Mortality and Morbidity

    9 years

Study Arms (1)

Sub-arachnoid Hemorrhage Patients

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

We recruited 448 patients between 2011 and 2020. However, 60 patients (13.4%) had incomplete records and were excluded from the analysis. Herein we present the retrospective analysis of the 388 patients (86.6%) with complete records. We received a median of 40.0 patients annually (IQR=51.5), and a peak was observed in 2017 when 76 SAH patients were admitted at our institution.

You may qualify if:

  • Sub-arachnoid Hemorrhage admission

You may not qualify if:

  • Not admitted for sub-arachnoid hemorrhage

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fann Teaching Hospital

Dakar, Senegal

Location

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
OTHER
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 17, 2021

First Posted

August 23, 2021

Study Start

April 26, 2021

Primary Completion

August 16, 2021

Study Completion

August 16, 2021

Last Updated

August 23, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Locations